Drug · DIN 02278383
VANTAS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 7, 2017; first marketed July 14, 2006.
- Drug Identification Number (DIN)
- 02278383
- Company (DIN owner)
- Paladin Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Implant; Kit
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Histrelin L02AE05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HISTRELIN ACETATE | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 10, 2006: NOC 7822New Drug Submission (NDS)